brolucizumab

Ukraine

Drugs containing this active substance

  • VISQUE

    The drug is intended for the treatment of adult patients with neovascular (exudative) age-related macular degeneration (AMD) and visual impairment due to diabetic macular edema (DME).

    Form: solution for injection

    Active substance Dosage
    brolucizumab 120 mg/ml

    ATC: S01LA06

    Manufacturer: Novartis Manufacturing NV (batch release)